Nancy M. Wyant
VP, Clinical Development Operations
Nancy Wyant is vice president, head of clinical operations at Stoke Therapeutics. Previously, she was an independent clinical program management and operations consultant, during which time she collaborated with Stoke on several key projects. Prior to this role, Nancy was vice president of clinical operations at BeiGene USA, Inc. In this position, she supported global clinical programs in oncology, managed compliance standards and oversaw clinical trial execution. Prior to BeiGene, Nancy served as vice president and head of clinical operations at Idera Pharmaceuticals, Sarepta Therapeutics and Shire Human Genetics Therapies. Nancy has also held management roles at EMD Serono, Therion Biologics Corporation and Vertex Pharmaceuticals, where she led clinical operations and clinical compliance programs. Nancy began her career at Massachusetts General Hospital as a clinical research and program coordinator. She is a member of Linking Leaders Boston and the American Epilepsy Society and has a B.A. in psychology from Hartwick College.